Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 23;16(6):e62996.
doi: 10.7759/cureus.62996. eCollection 2024 Jun.

Association of Vascular Endothelial Growth Factor (VEGF) and Mouse Model Minute 2 (MDM2) Polymorphisms With Diabetic Retinopathy in a Northwest Indian Population: A Case-Control Study

Manroop Singh Buttar  1 , Kamlesh Guleria  1 , Swarkar Sharma  2 , Ajs Bhanwer  3 , Vasudha Sambyal  1
Affiliations

Association of Vascular Endothelial Growth Factor (VEGF) and Mouse Model Minute 2 (MDM2) Polymorphisms With Diabetic Retinopathy in a Northwest Indian Population: A Case-Control Study

Manroop Singh Buttar et al. Cureus. .

Abstract

Introduction: Diabetic retinopathy (DR), a microvascular complication of type 2 diabetes (T2D), results from complex interactions of genetic and environmental factors. Vascular endothelial growth factor (VEGF) and mouse model minute 2 (MDM2)are upregulated in the retina due to diabetes, which increases the risk of DR. VEGFA and MDM2 genetic variations can influence DR risk. The present case-control study was conducted to evaluate the association of VEGFA and MDM2 promoter variants with DR in a population from Punjab, Northwest India.

Methods: A total of 414 DR patients, 425 T2D patients without DR, and 402 healthy controls were screened for VEGFA -2578C/A (rs699947), VEGFA -2549I/D (rs35569394), VEGFA -7C/T (rs25648), and MDM2 rs3730485 polymorphisms using polymerase chain reaction (PCR)-based methods.

Results: VEGFA -2549 I allele (OR = 1.35 (1.00-1.81), p = 0.043) and II genotype (OR = 1.78 (1.00-3.15), p = 0.047) were significantly associated with increased risk of DR. VEGFA -7 CT genotype conferred reduced risk of DR (OR = 0.28 (0.20-0.38); p = <0.001). VEGFA -2578 and MDM2 rs3730485 showed no significant association with DR. A-I-T (OR = 0.30 (0.20-0.44); p = <0.001) and C-D-T (OR = 0.33 (0.16-0.65); p = 0.002) haplotypes of rs699947-rs35569394-rs25648 polymorphisms showed decreased risk of DR.

Conclusions: I allele and II genotype of VEGFA -2549, CT genotype of VEGFA -7, and C-I-C and A-D-C haplotypes of rs699947-rs35569394-rs25648 polymorphisms were significantly associated with DR risk in a Northwest Indian population. This is the first study worldwide to report DR risk with VEGFA promoter variants together.

Keywords: capn10; diabetic retinopathy; genetic opthalmology; genetics; human genetics; mcp-1; polymorphism.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent was obtained or waived by all participants in this study. Institutional Ethics Committee of Guru Nanak Dev University issued approval Letter No. 573/HG, Dated- 29/03/2018. This study was approved by the Institutional Ethics Committee of Guru Nanak Dev University, Amritsar, Punjab, India (Letter No. 573/HG, Dated- 29/03/2018). Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Part of electropherograms (forward strand) showing CC, CA, and AA genotypes of VEGFA rs699947 (a) polymorphism. Part of electropherograms (forward strand) showing C- and T-specific primer sequencing results of VEGFA rs25648 (b) polymorphism
Figure 2
Figure 2. Part of electropherograms (forward strand) showing II, ID, and DD genotypes of VEGFA rs35569394 (a) and MDM2 rs3730485 (b) polymorphisms
See this image and copyright information in PMC

References

    1. Risk of cause-specific death in individuals with diabetes: a competing risks analysis. Baena-Díez JM, Peñafiel J, Subirana I, et al. Diabetes Care. 2016;39:1987–1995. - PubMed
    1. Sikka R, Babu IR, Singh G, Kaur I, Chhablani JK, Bhanwer AJS, Chakrabarti S. Human Genomics and Applications. Delhi, India: Narendra Publishing House; 2017. Some insights on the genomics of diabetic, retinopathy.
    1. [Epidemiological features of type 2 diabetes] Simon D. https://pubmed.ncbi.nlm.nih.gov/20465117/ Rev Prat. 2010;60:469–473. - PubMed
    1. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. Diabetes Res Clin Pract. 2018;138:271–281. - PubMed
    1. Prevalence of diabetic retinopathy in the United States, 2005-2008. Zhang X, Saaddine JB, Chou CF, et al. JAMA. 2010;304:649–656. - PMC - PubMed

LinkOut - more resources